Glimex PM 2mg/500mg/15mg Tablet ER
Marketer
Zivago Pharma Private Limited
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimex PM 2mg/500mg/15mg Tablet ER
Combiflex DM, a 2mg/500mg/15mg extended-release tablet, manages blood glucose in adults with type 2 diabetes. Used alongside diet and exercise, it enhances insulin effectiveness, reducing blood sugar. Follow your doctor's prescribed dosage and regimen; take with food to prevent stomach discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; never double a dose. Overdosing can cause dangerously low blood sugar (hypoglycemia). Hypoglycemia may occur with concurrent antidiabetic medications, alcohol consumption, or skipped meals; regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Disclose kidney, liver, or heart conditions to your physician before commencing treatment. Pregnant or nursing individuals should consult their doctor. Kidney function tests are typically performed before treatment initiation. Limit alcohol consumption to minimize potential side effects.
Uses of Glimex PM 2mg/500mg/15mg Tablet ER
Managing type 2 diabetes
Major Benefits of Glimex PM 2mg/500mg/15mg Tablet ER:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Glimex PM 2mg/500mg/15mg Extended-Release tablet should be administered with a meal.
Common Side effects of Glimex PM 2mg/500mg/15mg Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimex PM 2mg/500mg/15mg Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the entire tablet; do not crush, chew, or break it. Consume Glimex PM 2mg/500mg/15mg Extended-Release tablets with food.
How Glimex PM 2mg/500mg/15mg Tablet ER works:
Glimex PM 2mg/500mg/15mg Extended-Release tablets contain glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their combined action improves blood glucose management when monotherapy or dual-drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, complements this by further increasing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimex PM 2mg/500mg/15mg Extended-Release Tablets with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
The extended-release Glimex PM 2mg/500mg/15mg tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glimex PM tablets (2mg/500mg/15mg) are likely unsuitable for use while breastfeeding. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Glimex PM 2mg/500mg/15mg Extended-Release tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. For individuals with severe kidney disease, Glimex PM 2mg/500mg/15mg Extended-Release tablets are contraindicated. Regular monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimex PM 2mg/500mg/15mg Extended-Release tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Glimex PM 2mg/500mg/15mg Extended-Release tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimex PM 2mg/500mg/15mg Tablet ER :
Should you forget a Glimex PM 2mg/500mg/15mg Extended-Release Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimex PM 2mg/500mg/15mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently